A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Medizinische Universität Wien, Vienna

Prince of Wales Hospital, Randwick

Macarthur Cancer Therapy Centre, Campbelltown

Landesklinikum St. Pölten, Sankt Pölten

HOCA - the Wesley Clinic for Heamatology and Oncology, Auchenflower

Mater Medical Center, South Brisbane

Klinikum Wels-Grieskirchen GmbH, Wels

Hospital Universitari Vall d'Hebron, Barcelona

Arena Oncology Associates, Lake Success

UPMC Cancer Pavillion, Pittsburgh

Ospedale San Raffaele S.r.l., Milan

Azienda Ospedaliera Niguarda Cà Granda, Milan

Fairfax-Northern Virginia Haematology-Oncology, Fairfax

Virginia Cancer Institute, Richmond

Hospital Clinico San Carlos, Madrid

Hospital Universitario 12 de Octubre, Madrid

Florida Cancer Specialist, Tavares

Florida Cancer Specialists, Englewood

Azienda Ospedaliera Universitaria Integrata Di Verona, Verona

Tennessee Oncology PLLC, Nashville

Kliniken Essen-Mitte, Essen

Municipal institution Multifield City Clinical Hospital #4 of Dnipropetrovsk Regional Council, Dnipropetrovsk

Froedtert and Medical College ID Clinic, Milwaukee

Ospedale Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotundo

Hôpital Saint Antoine, Paris

South Texas Oncology and Hematology (STOH), San Antonio

University of Colorado Cancer Center, Aurora

TGen Clinical Research Services, Scottsdale

Pacific Shores Medical Group, Long Beach

Hôpital Beaujon, Clichy

Fred Hutchinson Cancer Research Center, Seattle

Mayo Clinic, Scottsdale

Indiana University, Indianapolis

University of Massachusetts Memorial Medical Center, Worcester

Tom Baker Cancer Centre, Calgary

British Columbia Cancer Agency, Vancouver

Royal Victoria Regional Health Centre, Barrie

Centre Hospsitalier Universitaire de Montreal - Notre Dame, Montreal

LMU Klinikum der Universität München, München